`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`____________
`
`COALITION FOR AFFORDABLE DRUGS II LLC.
`Petitioner
`v.
`
`NPS PHARMACEUTICALS, INC.
`Patent Owner
`
`____________
`
`Case IPR2015-00990
`
`Patent 7,056,886
`
`____________
`
`NPS PHARMACEUTICALS, INC.’s
`
`TOPICS FOR EXAMINATION OF PETITIONER
`
`
`
`
`
`1
`
`NPS EX. 2003
`CFAD v. NPS
`IPR2015-00990
`
`
`
`Patent Owner NPS Pharmaceuticals, Inc. (“NPS”) requests Petitioner to
`
`produce a witness to testify on behalf of Petitioner on the following topics pursuant
`
`to Federal Rule of Civil Procedure 30(b)(1) and Office Patent Trial Practice Guide.
`
`Definitions for NPS’s Requests for Production are incorporated-by-reference
`
`herein.
`
`TOPIC No. 1.
`
`The formation, organization, financials, personnel, and governance
`
`documents of each Named and Unnamed Funder.
`
`TOPIC No. 2.
`
`Any funding, co-mingling, ownership, opportunity sharing, and cooperation
`
`between or among any Named and Unnamed Funders.
`
`TOPIC No. 3.
`
`The ownership of or investment in any shares or any rights or obligations
`
`with respect to any shares or stock of Shire PLC and its affiliates by any Named or
`
`Unnamed Funders.
`
`
`
`2
`
`